Product screening
Antibodies
Proteins
Group VI iPLA2 Polyclonal Antibody
Alias:PLA2G6;PLPLA9;85/88 kDa calcium-independent phospholipase A2;CaI-PLA2;Group VI phospholipase A2;GVI PLA2;Intracellular membrane-associated calcium-independent phospholipase A2 beta;iPLA2-beta;Patatin-like phospholipase domain-contai
CatalogNo:HJRLT2073
Specifications
50μL;100μL
Delivery date
Spot
Target
Group VI iPLA2
Reactivity
Human,Mouse,Rat
Application - After Update
WB,ELISA
MW(Observed)
90kD
Host Species
Rabbit
Isotype
IgG
Modify
Unmodified
Recommended dilution ratio
WB 1:500-1:2000;ELISA 1:5000;Not yet tested in other applications.
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
Synthesized peptide derived from the Internal region of human Group VI iPLA2.
Specificity
Group VI iPLA2 Polyclonal Antibody detects endogenous levels of Group VI iPLA2 protein.
Gene name
PLA2G6
Protein name
85/88 kDa calcium-independent phospholipase A2
Organism-1
Human